• Rottlerin: Precision PKCδ Inhibition for Translational Impac

  2026-05-11

  Explore how Rottlerin, a selective PKCδ inhibitor, transforms translational research by bridging mechanistic insight with evidence-based guidance. This article dissects its role in modulating cell proliferation, apoptosis, and viral entry, connecting peer-reviewed findings with workflow optimization and competitive positioning for advanced applications.

• Dehydroepiandrosterone (DHEA): Optimizing Neuroprotection an

  2026-05-10

  Leverage Dehydroepiandrosterone (DHEA) for robust models in neuroprotection and ovarian biology, with protocol-ready parameters and troubleshooting tips informed by the latest research. Discover how APExBIO’s DHEA streamlines experimental success, from apoptosis inhibition to granulosa cell proliferation.

• MAPK10 Phosphorylation of KRT16 Suppresses NSCLC Metastasis

  2026-05-09

  This study reveals that mitogen-activated protein kinase 10 (MAPK10) inhibits non-small cell lung cancer (NSCLC) metastasis by promoting phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). The findings identify the MAPK10/KRT16/RNF213 axis as a potential prognostic biomarker and therapeutic target in NSCLC, opening new avenues for molecular pathway research and intervention.

• EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC: Chemo

  2026-05-08

  This study pioneers a chemogenetic screening strategy to identify synthetic lethal targets in MYC-driven triple-negative breast cancer (TNBC), pinpointing EphA2 inhibition as a promising vulnerability. The findings highlight the therapeutic potential of targeting EphA2 in aggressive, MYC-activated TNBC, with robust experimental validation and translational implications.

• CHI3L1-IN-5 (Compound Z17): Optimizing Neuroinflammation Ass

  2026-05-08

  CHI3L1-IN-5 (Compound Z17) empowers translational research by uniquely enabling both suppression of CHI3L1-mediated NF-κB signaling and restoration of amyloid-beta clearance in astrocytes. This protocol-centric guide translates recent mechanistic advances into robust workflows for modeling and modulating neuroinflammatory cascades in Alzheimer's disease.

• Latrunculin A: Reversible Inhibitor of Actin Assembly in Res

  2026-05-07

  Latrunculin A empowers high-precision, reversible actin cytoskeleton disruption for advanced cell morphology and virology studies. Learn how recent proteomic insights and optimized protocols elevate reproducibility and mechanistic clarity in cytoskeletal and host-pathogen research.

• DOT1L Inhibition Enhances Immunomodulatory Drug Response in

  2026-05-07

  This study demonstrates that inhibition of DOT1L reprograms innate immune signaling in multiple myeloma (MM), leading to potentiation of immunomodulatory drug (IMiD) efficacy. By dissecting the mechanistic interplay between DOT1L, interferon signaling, and DNA damage pathways, the research identifies DOT1L as a critical epigenetic target for overcoming therapeutic resistance in MM.

• Chemically Modified SOD2 mRNA-LNPs Mitigate Renal IRI in Mic

  2026-05-06

  This study demonstrates that lipid nanoparticle (LNP)-delivered, chemically modified SOD2 mRNA can significantly reduce renal injury following ischemia-reperfusion in mice. By leveraging optimized mRNA design and delivery, the research offers mechanistic and translational insight into mRNA therapeutics for acute kidney injury.

• Erastin as a Ferroptosis Inducer: Mechanisms, Protocols, and

  2026-05-06

  Explore how Erastin, a potent ferroptosis inducer, advances cancer biology research and immunotherapy. This article uniquely details the immunological synergy and protocol nuances that set Erastin apart.

• Mechanical Forces Activate GABAB Receptor Independent of GAB

  2026-05-05

  This study uncovers a novel, ligand-independent mechanism for GABAB receptor activation, showing that mechanical forces such as shear stress directly induce receptor signaling via integrin-GB1 interactions. These insights expand our understanding of mechanotransduction in the central nervous system and highlight new research avenues for cytoskeletal and signaling studies.

• Bestatin (Ubenimex): Advanced Workflows for Aminopeptidase I

  2026-05-05

  Bestatin (Ubenimex) from APExBIO empowers researchers to precisely measure and manipulate aminopeptidase activity in cancer and multidrug resistance studies. This guide delivers actionable protocol parameters, troubleshooting strategies, and a translational bridge from angiogenesis research to practical bench workflows.

• Dissecting Drug Responses: Growth Inhibition vs. Cell Death

  2026-05-04

  Schwartz’s dissertation advances cancer drug evaluation by distinguishing between drug-induced growth inhibition and cell death using in vitro methods. This nuanced approach uncovers the distinct timing and proportion of these effects, enabling more precise mechanistic studies and translational insights for anti-cancer drug development.

• Strategic Application of SAG in Translational Hedgehog Pathw

  2026-05-04

  This article provides a mechanistic and strategic framework for deploying Smoothened Agonist (SAG) in translational Hedgehog pathway research. We synthesize evidence from disease models, competitive antagonism, and recent literature—including medulloblastoma studies—to guide stem cell, neuroregeneration, and oncology investigators. Protocol recommendations, experimental pitfalls, and a forward-looking translational outlook are provided for maximum impact.

• LDN-193189: Mechanistic Insights and Assay Design for BMP Pa

  2026-05-03

  Explore how LDN-193189, a selective ALK inhibitor, elevates BMP signaling research through rigorous mechanistic understanding and nuanced assay optimization. This article uniquely bridges molecular mechanisms with practical protocol guidance for advanced epithelial and stem cell studies.

• Spiroplasma eriocheiris Entry into Drosophila S2 Cells: Endo

  2026-05-02

  This study systematically elucidates the cellular entry mechanisms of Spiroplasma eriocheiris in Drosophila Schneider 2 (S2) cells, identifying reliance on clathrin-mediated endocytosis and macropinocytosis. The findings provide a refined invertebrate model for understanding Spiroplasma infection biology, guiding research on host-pathogen interactions and potential intervention strategies.

620 records 9/42 page Previous Next First page 上5页 678910 下5页 Last page